Clinical outcomes of patients infected with HIV through use of injected drugs compared to patients infected through sexual transmission: late presentation, delayed anti-retroviral treatment and higher mortality.
Por:
Suárez-García I, Sobrino-Vegas P, Dalmau D, Rubio R, Iribarren JA, Blanco JR, Gutierrez F, Montero Alonso M, Bernal E, Vinuesa García D, Del Amo J and CoRIS
Publicada:
1 jul 2016
Ahead of Print:
17 feb 2016
Resumen:
To compare patients who acquired HIV infection through use of injected drugs (HIV-IDU) with patients who acquired HIV by sexual transmission (HIV-ST) in terms of late presentation (LP), delay in anti-retroviral treatment (ART) initiation, virological and immunological response to ART, mortality and progression to AIDS.
Filiaciones:
Suárez-García I:
Infectious Diseases Unit, Department of Internal Medicine, Hospital Universitario Infanta Sofía, San Sebastián de los Reyes, Madrid, Spain
Sobrino-Vegas P:
Centro Nacional de Epidemiología, Instituto de Salud Carlos III, Madrid, Spain
Dalmau D:
Hospital Universitari Mutua Terrassa, Terrassa, Spain
Rubio R:
Unidad Infección VIH, Hospital Universitario Doce de Octubre, Madrid, Spain
Iribarren JA:
Department of Infectious Diseases, Hospital Universitario Donostia, Donostia, Gipuzkoa, Spain
Blanco JR:
Department of Infectious Diseases, Hospital San Pedro-CIBIR, Logroño, Spain
:
Infectious Diseases Unit, Hospital General de Elche & Universidad Miguel Hernández, Elche, Alicante, Spain
Montero Alonso M:
Department of Infectious Diseases, Hospital Universitario La Fe, Valencia, Spain
Bernal E:
Hospital Reina Sofía, Murcia, Spain
Vinuesa García D:
Unidad de Gestion Clínica de Microbiología y Enfermedades Infecciosas, Hospital Clínico San Cecilio, Granada, Spain
Del Amo J:
Centro Nacional de Epidemiología, Instituto de Salud Carlos III, Madrid, Spain
|